Showing 1 - 20 results of 26 for search 'E V Privalova', query time: 0.07s
Refine Results
-
1
Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure by E. V. Privalova
Published 2007-06-01
Article -
2
Hypertrophic cardiomyopathy: course characteristics in long-term follow-up by Iu N Belenkov, E V Privalova, V Iu Kaplunova, A A Fomin
Published 2008-08-01
Article -
3
-
4
The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabe... by O. A. Slepova, A. S. Lishuta, E. Yu. Vasiltsova, E. V. Privalova, Yu. N. Belenkov
Published 2022-07-01
Article -
5
CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN C... by E. V. Privalova, V. Yu. Kaplunova, N. V. Khabarova, G. A. Shakaryants, Yu. N. Belenkov
Published 2013-02-01
Article -
6
Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellit... by A. V. Zhito, A. O. Iusupova, E. V. Privalova, N. V. Khabarova, Yu. N. Belenkov
Published 2020-01-01
Article -
7
-
8
Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus by Yu. N. Belenkov, E. V. Privalova, I. S. Chekneva, L. V. Knyazeva, N. S. Suleymanova, I. V. Vasilyeva
Published 2011-02-01
Article -
9
POSSIBILITIES OF ENHANCED EXTERNAL COUNTERPULSATION USING IN CLINICAL PRACTICE by Z. A. Mamieva, A. S. Lishuta, Yu. N. Belenkov, E. V. Privalova, A. O. Yusupova, S. M. Rykova
Published 2017-05-01
Article -
10
Effectiveness of different treatment regimens of enhanced external counterpulsation in patients with stable coronary artery disease complicated by heart failure by A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov
Published 2024-03-01
Article -
11
-
12
-
13
Evaluation of Fibrosis Markers as a Potential Method for Diagnosing Non-Obstructive Coronary Artery Disease in Patients with Stable Coronary Artery Disease by N. N. Pakhtusov, A. O. Yusupova, K. A. Zhbanov, A. A. Shchedrygina, E. V. Privalova, Yu. N. Belenkov
Published 2023-01-01
Article -
14
-
15
INFLUENCE OF THE COMBINATION DRUG PRESTANS (PERINDOPRIL A, AMLODIPINE) ON MORPHO-FUNCTIONAL PARAMETERS OF ARTERIAL BED IN ESSENTIAL HYPERTENSION by Yu. A. Danilogorskaya, E. A. Zheleznykh, E. V. Privalova, A. A. Shchendrygina, Yu. N. Belenkov, I. S. Ilgisonis, M. I. Tishman
Published 2017-12-01
Article -
16
-
17
EFFECTS OF PERINDOPRIL, TELMISARTAN, AND THEIR COMBINATIONS ON CLINICAL, FUNCTIONAL, AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELL... by Yu. N. Belenkov, E. V. Privalova, E. A. Zheleznykh, Yu. A. Danilogorskaya, I. S. Chekneva, O. A. Azizova, A. V. Aseychev, A. G. Shvachko
Published 2010-04-01
Article -
18
-
19
-
20
Plasma Level’s of Neuregulin-1 in Healthy People by K. A. Zhbanov, A. A. Shchendrygina, E. A. Zheleznykh, E. V. Privalova, A. Y. Suvorov, A. S. Ablyametova, N. F. Fuksman, E. Yu. Salakheeva, Yu. N. Belenkov
Published 2022-01-01
Article